Ras-Mediated Deregulation of the Circadian Clock in Cancer

PLoS Genetics

Volumn 10, Issue 5, 2014, Pages

  Relógio, Angela ^a   Thomas, Philippe ^a   Medina Pérez, Paula ^b   Reischl, Silke ^b   Bervoets, Sander ^a   Gloc, Ewa ^b   Riemer, Pamela ^b   Mang Fatehi, Shila ^b   Maier, Bert ^b   Schäfer, Reinhold ^b,c   Leser, Ulf ^a   Herzel, Hanspeter ^a   Kramer, Achim ^b   Sers, Christine ^b,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LENTIVIRUS VECTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BMAL1; RAS PROTEIN; RNA; KRAS PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; ONCOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER CELL LINE; CARCINOGENESIS; CIRCADIAN RHYTHM; COLON CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SYNTHESIS; FIBROBLAST; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IFNGR2 GENE; KERATINOCYTE; LOXL2 GENE; MICROARRAY ANALYSIS; MOUSE; NEOPLASM; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; PITX2 GENE; PPAR GAMMA GENE; PROTEIN EXPRESSION; RAB6 GENE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RFWD2 GENE; RNA ISOLATION; SIGNAL TRANSDUCTION; SKIN CANCER; SPARC GENE; SYSTEMS BIOLOGY; TUMOR GENE; WESTERN BLOTTING; BIOSYNTHESIS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; SKIN TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CIRCADIAN CLOCKS; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84901594242     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004338     Document Type: Article

References (103)

1. Young MW, Kay SA, (2001) Time zones: a comparative genetics of circadian clocks. Nat Rev Genet 2: 702-715.
2. Bell-Pedersen D, Cassone VM, Earnest DJ, Golden SS, Hardin PE, et al. (2005) Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 6: 544-556.
3. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, et al. (2002) Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109: 307-320.
4. Hankins MW, Peirson SN, Foster RG, (2008) Melanopsin: an exciting photopigment. Trends Neurosci 31: 27-36.
5. Stokkan KA, Yamazaki S, Tei H, Sakaki Y, Menaker M, (2001) Entrainment of the circadian clock in the liver by feeding. Science 291: 490-493.
6. Suter DM, Schibler U, (2009) Physiology. Feeding the clock. Science 326: 378-379.
7. Albrecht U, (2012) Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 74: 246-260.
8. Takahashi JS, Shimomura K, Kumar V, (2008) Searching for genes underlying behavior: lessons from circadian rhythms. Science 322: 909-912.
9. Brown SA, Kowalska E, Dallmann R, (2012) (Re)inventing the circadian feedback loop. Dev Cell 22: 477-487.
10. Ueda HR, Hayashi S, Chen W, Sano M, Machida M, et al. (2005) System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat Genet 37: 187-192.
11. Relogio A, Westermark PO, Wallach T, Schellenberg K, Kramer A, et al. (2011) Tuning the mammalian circadian clock: robust synergy of two loops. PLoS Comput Biol 7: e1002309.
12. Wallach T, Schellenberg K, Maier B, Kalathur RK, Porras P, et al. (2013) Dynamic circadian protein-protein interaction networks predict temporal organization of cellular functions. PLoS Genet 9: e1003398.
13. Bozek K, Relogio A, Kielbasa SM, Heine M, Dame C, et al. (2009) Regulation of clock-controlled genes in mammals. PLoS One 4: e4882.
14. Bass J, (2012) Circadian topology of metabolism. Nature 491: 348-356.
15. Masri S, Zocchi L, Katada S, Mora E, Sassone-Corsi P, (2012) The circadian clock transcriptional complex: metabolic feedback intersects with epigenetic control. Ann N Y Acad Sci 1264: 103-109.
16. Takahashi JS, Hong HK, Ko CH, McDearmon EL, (2008) The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 9: 764-775.
17. Sahar S, Sassone-Corsi P, (2009) Metabolism and cancer: the circadian clock connection. Nat Rev Cancer 9: 886-896.
18. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, et al. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259.
19. Kondratova AA, Kondratov RV, (2012) The circadian clock and pathology of the ageing brain. Nat Rev Neurosci 13: 325-335.
20. Fu L, Lee CC, (2003) The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3: 350-361.
21. Rafnsson V, Tulinius H, Jonasson JG, Hrafnkelsson J, (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12: 95-101.
22. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, et al. (2006) Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol 164: 549-555.
23. Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, et al. (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6: 3038-3045.
24. Filipski E, Levi F, (2009) Circadian disruption in experimental cancer processes. Integr Cancer Ther 8: 298-302.
25. Levi F, Okyar A, Dulong S, Innominato PF, Clairambault J, (2010) Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol 50: 377-421.
26. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, et al. (2006) The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22: 375-382.
27. Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, et al. (2009) Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res 69: 3605-3613.
28. Fu L, Pelicano H, Liu J, Huang P, Lee C, (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111: 41-50.
29. Lis CG, Grutsch JF, Wood P, You M, Rich I, et al. (2003) Circadian timing in cancer treatment: the biological foundation for an integrative approach. Integr Cancer Ther 2: 105-111.
30. Levi F, Schibler U, (2007) Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 47: 593-628.
31. Bernard S, Cajavec Bernard B, Levi F, Herzel H, (2010) Tumor growth rate determines the timing of optimal chronomodulated treatment schedules. PLoS Comput Biol 6: e1000712.
32. Hrushesky WJ, Grutsch J, Wood P, Yang X, Oh EY, et al. (2009) Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther 8: 387-397.
33. Innominato PF, Levi FA, Bjarnason GA, (2010) Chronotherapy and the molecular clock: Clinical implications in oncology. Adv Drug Deliv Rev 62: 979-1001.
34. Gaddameedhi S, Reardon JT, Ye R, Ozturk N, Sancar A, (2012) Effect of circadian clock mutations on DNA damage response in mammalian cells. Cell Cycle 11: 3481-3491.
35. Sancar A, Lindsey-Boltz LA, Kang TH, Reardon JT, Lee JH, et al. (2010) Circadian clock control of the cellular response to DNA damage. FEBS Lett 584: 2618-2625.
36. Kowalska E, Ripperger JA, Hoegger DC, Bruegger P, Buch T, et al. (2012) NONO couples the circadian clock to the cell cycle. Proc Natl Acad Sci U S A 110: 1592-9.
37. Borgs L, Beukelaers P, Vandenbosch R, Belachew S, Nguyen L, et al. (2009) Cell "circadian" cycle: new role for mammalian core clock genes. Cell Cycle 8: 832-837.
38. Wood PA, Du-Quiton J, You S, Hrushesky WJ, (2006) Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 5: 2023-2033.
39. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P, (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324: 654-657.
40. Brooks CL, Gu W, (2009) How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 9: 123-128.
41. Kondratov RV, Antoch MP, (2007) Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 17: 311-317.
42. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, et al. (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26: 1241-1246.
43. Hua H, Wang Y, Wan C, Liu Y, Zhu B, et al. (2006) Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 97: 589-596.
44. Chen-Goodspeed M, Lee CC, (2007) Tumor suppression and circadian function. J Biol Rhythms 22: 291-298.
45. Yang WS, Stockwell BR, (2008) Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest. Genome Biol 9: R92.
46. Yi CH, Zheng T, Leaderer D, Hoffman A, Zhu Y, (2009) Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis. Cancer Lett 284: 149-156.
47. Alhopuro P, Bjorklund M, Sammalkorpi H, Turunen M, Tuupanen S, et al. (2010) Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res 8: 952-960.
48. Levi F, Filipski E, Iurisci I, Li XM, Innominato P, (2007) Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. Cold Spring Harb Symp Quant Biol 72: 465-475.
49. Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, et al. (2009) A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 139: 199-210.
50. Thomas P, Starlinger J, Vowinkel A, Arzt S, Leser U, (2012) GeneView: a comprehensive semantic search engine for PubMed. Nucleic Acids Res 40: W585-591.
51. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, et al. (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 9: 489-499.
52. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, et al. (2010) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-568.
53. Schroder K, Hertzog PJ, Ravasi T, Hume DA, (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189.
54. Fusenig NE, Boukamp P, (1998) Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 23: 144-158.
55. Liu HS, Scrable H, Villaret DB, Lieberman MA, Stambrook PJ, (1992) Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res 52: 983-989.
56. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T, (1993) Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85-88.
57. Shi SQ, Ansari TS, McGuinness OP, Wasserman DH, Johnson CH, (2013) Circadian disruption leads to insulin resistance and obesity. Curr Biol 23: 372-381.
58. Kondratov RV, Kondratova AA, Gorbacheva VY, Vykhovanets OV, Antoch MP, (2006) Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock. Genes Dev 20: 1868-1873.
59. Janich P, Pascual G, Merlos-Suarez A, Batlle E, Ripperger J, et al. (2011) The circadian molecular clock creates epidermal stem cell heterogeneity. Nature 480: 209-214.
60. Ballesta A, Dulong S, Abbara C, Cohen B, Okyar A, et al. (2011) A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery. PLoS Comput Biol 7: e1002143.
61. Li Q, Wang X, Lu Z, Zhang B, Guan Z, et al. (2010) Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus. PLoS One 5: e13732.
62. Kim MS, Chung NG, Kang MR, Yoo NJ, Lee SH, (2011) Genetic and expressional alterations of CHD genes in gastric and colorectal cancers. Histopathology 58: 660-668.
63. Wu S, Shi Y, Mulligan P, Gay F, Landry J, et al. (2007) A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol 14: 1165-1172.
64. Majumder P, Gomez JA, Chadwick BP, Boss JM, (2008) The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions. J Exp Med 205: 785-798.
65. Majumder P, Boss JM, (2010) CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus. Mol Cell Biol 30: 4211-4223.
66. Merkenschlager M, Odom DT, (2013) CTCF and Cohesin: Linking Gene Regulatory Elements with Their Targets. Cell 152: 1285-1297.
67. Sassone-Corsi P, (2013) Physiology. When metabolism and epigenetics converge. Science 339: 148-150.
68. Sassone-Corsi P, (2012) Minireview: NAD+, a circadian metabolite with an epigenetic twist. Endocrinology 153: 1-5.
69. Feng D, Lazar MA, (2012) Clocks, metabolism, and the epigenome. Mol Cell 47: 158-167.
70. Park JI, Kwak JY, (2012) The role of peroxisome proliferator-activated receptors in colorectal cancer. PPAR Res 2012: 876418.
71. Bradshaw AD, (2012) Diverse biological functions of the SPARC family of proteins. Int J Biochem Cell Biol 44: 480-488.
72. Mohamed MM, Sloane BF, (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6: 764-775.
73. Cano A, Santamaria PG, Moreno-Bueno G, (2012) LOXL2 in epithelial cell plasticity and tumor progression. Future Oncol 8: 1095-1108.
74. Sossey-Alaoui K, Li X, Ranalli TA, Cowell JK, (2005) WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase. J Biol Chem 280: 21748-21755.
75. Ye DZ, Kaestner KH, (2009) Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 137: 2052-2062.
76. Hossain MN, Sakemura R, Fujii M, Ayusawa D, (2006) G-protein gamma subunit GNG11 strongly regulates cellular senescence. Biochem Biophys Res Commun 351: 645-650.
77. Matise LA, Palmer TD, Ashby WJ, Nashabi A, Chytil A, et al. (2012) Lack of transforming growth factor-beta signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res 14: R98.
78. Harman FS, Nicol CJ, Marin HE, Ward JM, Gonzalez FJ, et al. (2004) Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. Nat Med 10: 481-483.
79. Luo F, Brooks DG, Ye H, Hamoudi R, Poulogiannis G, et al. (2009) Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways. Int J Exp Pathol 90: 558-574.
80. Spengler ML, Kuropatwinski KK, Schumer M, Antoch MP, (2009) A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and degradation. Cell Cycle 8: 4138-4146.
81. Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, et al. (2011) Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 25: 1439-1446.
82. Lengyel Z, Lovig C, Kommedal S, Keszthelyi R, Szekeres G, et al. (2012) Altered expression patterns of clock gene mRNAs and clock proteins in human skin tumors. Tumour Biol 34: 811-819.
83. Oshima T, Takenoshita S, Akaike M, Kunisaki C, Fujii S, et al. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep 25: 1439-1446.
84. Sanada K, Okano T, Fukada Y, (2002) Mitogen-activated protein kinase phosphorylates and negatively regulates basic helix-loop-helix-PAS transcription factor BMAL1. J Biol Chem 277: 267-271.
85. Williams JA, Su HS, Bernards A, Field J, Sehgal A, (2001) A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science 293: 2251-2256.
86. Weber F, Hung HC, Maurer C, Kay SA, (2006) Second messenger and Ras/MAPK signalling pathways regulate CLOCK/CYCLE-dependent transcription. J Neurochem 98: 248-257.
87. Nomura K, Takeuchi Y, Fukunaga K, (2006) MAP kinase additively activates the mouse Per1 gene promoter with CaM kinase II. Brain Res 1118: 25-33.
88. Hakenberg J, Gerner M, Haeussler M, Solt I, Plake C, et al. (2011) The GNAT library for local and remote gene mention normalization. Bioinformatics 27: 2769-2771.
89. Airola A, Pyysalo S, Bjorne J, Pahikkala T, Ginter F, et al. (2008) All-paths graph kernel for protein-protein interaction extraction with evaluation of cross-corpus learning. BMC Bioinformatics 9 Suppl 11: S2.
90. Tikk D, Thomas P, Palaga P, Hakenberg J, Leser U, (2010) A comprehensive benchmark of kernel methods to extract protein-protein interactions from literature. PLoS Comput Biol 6: e1000837.
91. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, et al. (2011) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 40: D13-25.
92. Kauffmann A, Gentleman R, Huber W, (2009) arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 25: 415-416.
93. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
94. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
95. Jeanmougin M, de Reynies A, Marisa L, Paccard C, Nuel G, et al. (2010) Should we abandon the t-test in the analysis of gene expression microarray data: a comparison of variance modeling strategies. PLoS One 5: e12336.
96. Kooperberg C, Aragaki A, Strand AD, Olson JM, (2005) Significance testing for small microarray experiments. Stat Med 24: 2281-2298.
97. Murie C, Woody O, Lee AY, Nadon R, (2009) Comparison of small n statistical tests of differential expression applied to microarrays. BMC Bioinformatics 10: 45.
98. Jeffery IB, Higgins DG, Culhane AC, (2006) Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics 7: 359.
99. McCall MN, Jaffee HA, Irizarry RA, (2012) fRMA ST: frozen robust multiarray analysis for Affymetrix Exon and Gene ST arrays. Bioinformatics 28: 3153-3154.
100. Sporl F, Schellenberg K, Blatt T, Wenck H, Wittern KP, et al. (2010) A circadian clock in HaCaT keratinocytes. J Invest Dermatol 131: 338-348.
101. Yoo SH, Yamazaki S, Lowrey PL, Shimomura K, Ko CH, et al. (2004) PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci U S A 101: 5339-5346.
102. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, et al. (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265.
103. Brown SA, Fleury-Olela F, Nagoshi E, Hauser C, Juge C, et al. (2005) The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biol 3: e338.